BIT’s 5th Annual World Congress of Vaccine (WCV2013)
BIT Congress Inc. is proud to announce that The 5th Annual World Congress of Vaccine (WCV) will take place during March 18-22, 2013 in Hangzhou, China, which will contribute to offering professionals in the field of vaccine a multidisciplinary informative platform.
The annual WCV Congress initiated by BIT Congress in 2008 has become accepted as an influential conference for worldwide vaccine professionals to discuss and develop the latest research breakthroughs as well as potential business opportunities.
WCV-2013 will highlight the theme “Better Innovation & Global Health” and aims to be the most comprehensive vaccine congress where discoveries meet opportunities; innovators meet developers; and science translates into business. The objective of this conference is to provide communication, education and networking opportunities for scientists engaged in vaccine whether in academia, biotech or industry. Attendees will hear world-class speakers discussing the challenges and opportunities facing the vaccines field.
With 9 Chapters consisting of 300 Oral Presentations, WCV-2013 will once again bring together thought leaders from pharmaceutical, biotech companies, consultants, regulatory authorities and academics, including well-known industry experts, innovative technology developers and expert scientists, to present the latest research results, ideas, developments, applications and business prospects in Vaccine Research and Technologies, Vaccine Design, Vaccine Engineering and Production, Vaccine Market Trend.
Attendance cost: $1399
Event organizer: BIT World Congress Inc.